Science Resources
Earth Science
Space Science
Life Science
Fields of Scientific Study
Medical Topics and Fields
Cancer Research
Nanotechnology Articles
RSS Feeds
|
 |
 |
 |
Space Technology Benefits Medical Community
February 01, 2007
A small group of APL researchers, in collaboration with physicians from the Johns Hopkins Scleroderma Center in Baltimore, developed and recently completed initial trials for a miniature device to help physicians characterize Raynaud's disease and measure treatment effectiveness. "The Ambulatory Raynaud's Monitor is a tiny, Band-Aid-like device that enables physicians to objectively characterize a patient's condition, determine its severity and measure symptoms in real time," says Dr. Frederick Wigley, director of the Hopkins Scleroderma Center and one of the country's leading scleroderma experts, who asked the Johns Hopkins University Applied Physics Laboratory (APL), in Laurel, Md., to develop the device after reading about APL's work developing miniature devices for spacecraft. "Until now, Raynaud's research has been crippled without such a device."
The small, low-cost monitor wraps around a patient's finger and is secured with a bandage or medical tape. It contains two sensors that alternately record skin and ambient temperatures - indicators of surface blood flow - every 36 seconds. Interactive controls permit a patient to record the date and time of a suspected Raynaud's attack. A week's data is held by the monitor's electronics and is retained even if the device's power is unexpectedly interrupted.
Physicians can easily download data into a computer or PDA (personal digital assistant). Software developed by APL enables physicians to quickly and easily display and plot data, which could be done during a patient's appointment to provide real-time feedback. The monitoring system's batteries store enough energy to operate for several months, and devices can be cleaned and reinitialized for use with multiple patients.
Triggered by cold temperatures or stress, Raynaud's is characterized by numbness and coldness in the fingers, toes, ears and/or nose when blood vessels in those areas constrict during attacks. Insufficient blood flow near the skin's surface also causes patients to experience skin color changes and varying levels of discomfort. Limited blood flow to the extremities can potentially lead to permanent loss of function. Raynaud's can occur on its own, or be secondary to another condition, such as auto-immune disorders like scleroderma or lupus.
Field Trials The device recently underwent initial testing on patients with Raynaud's being treated at the Johns Hopkins Medical Institutions. Patients wore a monitor for one week in their homes, pressing an "event button" on the device to indicate when a Raynaud's event was occurring. The data - processed by APL engineers and evaluated by JHMI physicians - indicates Raynaud's events can be successfully identified. Patients said the devices are comfortable and easy to use. "The data from this preliminary study suggests that the monitor can help scientists and physicians learn more about Raynaud's phenomenon and help investigators evaluate the effectiveness of drugs being developed to treat this disease," says APL's Binh Le, one of the inventors of the device.
Based on initial data, APL researchers have enhanced the monitor's design and are gearing up for the next round of trials at JHMI later this winter.
Other Applications In addition to monitoring Raynaud's patients, this platform technology could be used for an array of other medical or monitoring applications. The monitor could be modified to measure skin temperature of patients at risk for developing cardiovascular disease by tracking endothelial function (how small blood vessels regulate local blood flow to the tissues). Measuring skin temperature in various real-life situations may provide a noninvasive method to determine vascular responses in health and in various disease states.
With appropriate modifications, this monitoring system could also be used to track other physiological parameters, such as pulse rate and blood pressure, and transmit the information to remote call centers. Athletes, for example, could wear it to help measure their physiological performance throughout exercise routines.
The Applied Physics Laboratory
|
 |
Related Scleroderma Current Events and Scleroderma News Articles Scleroderma Current Events and Scleroderma News RSS Geneticists Hunt for Scleroderma Triggers At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.
Drug could provide first treatment for scleroderma Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive.
BUSM researchers identify better laser for treating facial spider veins Researchers from Boston University School of Medicine (BUSM) have concluded that the 940nm wavelength laser is superior for treating facial spider veins (telangiectasias) as compared to the 532nm wavelength laser.
Endothelin-Related Drugs Benefit Patients With Pulmonary Hypertension Recent research to block the effects of endothelin, a powerful substance that constricts blood vessels and stimulates cell growth, has led to successful treatment of pulmonary arterial hypertension and provides hope for treating other chronic diseases.
International conference on endothelin One of the most intriguing developments in recent medical science is the discovery of the human chemical endothelin (ET).
Survival instincts propel 'difficult patient' to insist on quality care Michelle Mayer had to become a "difficult patient" before she could get her physicians to accurately diagnose the disease that was destroying her health.
Dartmouth researchers discover gene signatures for scleroderma Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report.
UCSF marks a milestone with 500th transplant in heart and lung program UCSF marked a milestone this week with the 500th procedure in its Thoracic Transplant Program, which specializes in transplantation of the heart and lung.
Researchers show that fibrosis can be stopped, cured and reversed University of California, San Diego researchers have proven in animal studies that fibrosis in the liver can be not only stopped, but reversed.
Scleroderma Outlook Improves as Survival Increases Individuals with scleroderma are living significantly longer today, compared with 30 years ago, and the physicians who treat this rare disease of connective tissue hope the newer drugs now on the market may extend lives even further. More Scleroderma Current Events and Scleroderma News Articles
|
 |

|
Scleroderma: The Proven Therapy that Can Save Your Life
by Henry Scammell (Author)
Scleroderma, which affects as many as 400,000 Americans, starts off like skin cancer but is far more deadly. This new edition is updated with new information about the best therapy for this disease, including the results of the landmark first, and a new, second clinical trial of the only therapy to report reversal and remission of this deadly disease.
|

|
The Scleroderma Book: A Guide for Patients and Families
by Maureen D. Mayes M.D. (Author)
The Scleroderma Book has long been considered the leading source of information for patients suffering with this disease. Now comes the Second Edition of this highly respected volume, extensively revised by Maureen Mayes, M.D., the leading authority in this field. Writing specifically for patients and their families, Dr. Mayes draws on her extensive experience treating scleroderma to provide up-to-date, practical information that will help patients manage their symptoms and improve their quality of life. Dr. Mayes begins with an easily accessible description of the basic facts, distinguishing between the many manifestations of the disease, ranging from localized scleroderma (small patches of hardened skin, most common in children, which tend to clear up over time) to systemic scleroderma,...
|

|
The First Year: Scleroderma: An Essential Guide for the Newly Diagnosed (The First Year Series)
by Karen Gottesman (Author), M.D. Daniel E. Furst (Foreword)
Scleroderma-a chronic autoimmune condition that causes hardening, thickening, or tightening of the skin and attacks the heart, lungs, kidneys, and gastrointestinal tract-is extraordinarily difficult to diagnose and can take a huge toll on the psychological well-being of the individual. From the first moment of her diagnosis, author Karen Gottesman took charge and educated herself on every aspect of her condition. Now, as a "patient-expert," she guides those newly diagnosed step by step through their first year with scleroderma. She provides crucial information about the nature of the disease, treatment options, diet, exercise, social concerns, emotional issues, networking with others, and much more. The First Year™-Scleroderma is illustrated with charts and tables, and offers an...
|

|
A Journey Towards Health ... Reversing Scleroderma
by Jane M. Parker (Author), Victor Dyment (Author), Elieba Levine (Editor)
Answers do exist for seemingly incurable diseases. The information contained in this book applies to a diverse variety of conditions ranging from ADD, Autism, Scleroderma, and MS to psoriasis and eczema. We all have the ability to reach good health by changing to the correct materials such as dental, clothing and furniture.
This book follows Jane Parker's journey from the diagnosis of systemic Scleroderma, a fatal autoimmune disease, to good health. After a year of unanswered questions, numerous doctors and alternative practitioners, she finally received a correct diagnosis of Scleroderma. In researching the disease she found there was no known way to cure it.
All existing information held no hope for survival – and definitely none for a reversal, but this...
|

|
Voices of Scleroderma (Volume 3)
by International Scleroderma Network (Author)
“I highly recommend this book for patients, caregivers, and medical professionals who want quality medical information and support for scleroderma and related illnesses. “Access to high quality reliable modern information is crucial to patient well-being and outcomes. The realization that ‘you ARE NOT alone’ has therapeutic value in its own right. “The nonprofit International Scleroderma Network (ISN) and its website at www.sclero.org enjoys a well-deserved reputation for top-notch medical and support information and services from both the patient and medical organizations throughout the world. Each book in this series features enlightening articles from esteemed scleroderma researchers as well as over 100 unique patient and caregiver stories from 16 countries and in 5...
|

|
Connective Tissue Diseases: Holistic Therapy Options--Sjoegren¿s Syndrome; Systemic Sclerosis - Scleroderma; Systemic Lupus Erythematosus; Discoid Lupus Erythematosus; Secondary and Primary Raynaud¿s phenomenon; Raynaud¿s Disease; Polymyositis ¿ Dermatomyositis
by Hannelore Helbing-Sheafe (Author)
Hannelore Helbing-Sheafe’s constant struggle with her health was a powerful motivator to investigate possible ways to help herself and others. The focus of her practice was always on finding the cause of the problem and instructing patients in using correct nutrients and/or natural medicine and therapy to correct and reverse existing health problems. Her main focus has been to seek balance in all body systems. Connective Tissue Diseases - Holistic Therapy Options provides valuable information about holistic therapy options for patients afflicted with connective tissue (collagen) problems. Detailed information is given regarding current medical diagnostic procedures and treatment, followed by holistic therapy options. The book also provides details about the multiple,...
|

|
The Story of Jean: Ending Her Journey
At age 23, Jean Stevens was diagnosed with the rare disease Scleroderma, which affects the body's ability to produce the collagen needed to give the skin elasticity. Without collagen, facial features become transfixed, joints stiffen and eventually the body's vital organs can eventually harden. Jean faced the disease with the vibrancy and determination that was more than admirable -- it was inspirational. Yet a positive attitude wasn't enough to deflect the onslaught of yet another disease, this time cancer. The Story of Jean is a remarkable story about an equally remarkable woman afflicted with more than her share of trials. But Jean also considered herself blessed with more than her share of friends. With no family to stand with her, Jean's friends became her adopted family, her...
|

|
Voices of Scleroderma Volume 1
by International Scleroderma Network (Author)
A comprehensive book of scleroderma medical and support information, with articles by world experts in scleroderma and caregiving, as well as over 100 true stories from those affected by scleroderma.
|

|
Scleroderma Awareness Ribbon Mouse Pad
by MyHeritageWear.com
The Scleroderma Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Scleroderma Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your The Scleroderma Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Scleroderma Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Scleroderma Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style...
|

|
Clearly Charming Light Blue Ribbon Prostate, Lung Cancer, Trisomy 18, Scleroderma Italian Charm
by Clearly Charming
Light blue ribbon stands for prostate cancer, and Scleroderma awareness. It will make a great addition to your Italian charm bracelet or a perfect personalized gift. Commemorate special occasions, capture memorable moments, or simply show off your birthstone by creating your own original Italian charm bracelet. Add Clearly Charming premium quality interlocking modular Italian charm links to your Italian Charm Bracelet and create your own memory bracelet.
|
|